Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine

BACKGROUND: Chemotherapy either before or after surgery is a common breast cancer treatment. Long-term, high dose treatments with chemotherapeutic drugs often result in undesirable side effects, frequent recurrences and resistances to therapy. METHODS: The anti-cancer drug, gemcitabine (GEM) was use...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shan, Guo, Jinsong, Wei, Wendong, Zhang, Jue, Fang, Jing, Beebe, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209047/
https://www.ncbi.nlm.nih.gov/pubmed/25379013
http://dx.doi.org/10.1186/s12935-014-0098-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209047/
https://www.ncbi.nlm.nih.gov/pubmed/25379013
http://dx.doi.org/10.1186/s12935-014-0098-4

Ejemplares similares